CLINICAL_TRIALS
trial_result
· 2020-07-02
Clinical Trial Update: Open Label Safety Study in Acute Treatment of Migraine [Phase 2, Phase 3]
Summary
Open-label safety study in acute treatment of migraine completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Migraine, With or Without Aura | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-07-02